Insulin-Sensitizing Antihyperglycemic Drugs and Mortality After Acute Myocardial Infarction

2005101 citationsJournal Articlebronze Open Access

Authors

Silvio E. Inzucchi · Yale University

Frederick A. Masoudi · University of Colorado Denver

Yongfei Wang · Yale University

Mikhail Kosiborod · Yale University

JoAnne M. Foody · Yale University

John F. Setaro · Yale University

Edward P. Havranek ·

Abstract

Individually, prescription of insulin-sensitizing drugs is not associated with a significantly different risk of death in older diabetic patients within 1 year following AMI compared with other antihyperglycemic agents. Combined, however, metformin and TZDs may exert benefit. TZD prescription is associated with a higher risk of readmission for heart failure after myocardial infarction.

Topics & Keywords

Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Treatment and Management Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 28, Issue 7, pp. 1680-1689

DOI: 10.2337/diacare.28.7.1680

Field-Weighted Citation Impact: 6.99